Summary
The DIMS annual report 2024 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market. Spread out over all Dutch provinces, the DIMS network encompasses 33 testing-facilities providing nation-wide coverage. Together with these partners, DIMS aims to create a clear insight into the Dutch drug market, and signal potential health risks to the public.Download as PDF
Annual report DIMS 2024
PDF files are made available as a convenience. In cases where the EUDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.